XRP is seen heading back up again amid Middle East ceasefire

​​​XRP is seen heading back up again

​XRP bullish case:

​XRP swiftly recovered from Sunday's $1.9096 low - amid the bombardment of Iran's nuclear facilities by the US - to so far a one-week high at $2.2118 as President Trump announced a Middle East ceasefire.

​The May-to-June downtrend line and 55-day simple moving average (SMA) at $2.2585-to-$2.2598 are next in line.

​A rise above this resistance area could lead to the 11-to-16 June highs at $2.3381-to-$2.3370 being revisited.

​Above this resistance zone meanders the and 200-day SMA at $2.3743 and lies the 23 May high at $2.4801. Further up lies the May peak at $2.6542.

​XRP bearish case:

​A slip this week may lead to the $2.0845-to-$2.0360 support zone being probed. It consists of the mid-April-to-June lows.

​A fall and daily chart close below this support area may lead to the early April and late February lows at $1.9604-to-$1.9509 being revisited.

​Further potential support can be found between Sunday's $1.9096 low and the March low at $1.9011.

XRP daily candlestick chart

This information has been prepared by IG, a trading name of IG Markets Limited. In addition to the disclaimer below, the material in this article does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy of completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients. See full non-independent research disclaimer and quarterly summary.

The material does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. The research does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it.

It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients. We aim to establish and maintain and operate effective organisational and administrative arrangements with a view to taking all reasonable steps to prevent conflicts of interest from constituting or giving rise to a material risk of damage to the interests of our clients. We operate a policy of independence which requires our employees to act in our clients’ best interests and to disregard any conflicts of interests in providing our services. Furthermore, IG does not seek to disclose the relevant information to any issuer discussed prior to dissemination. The organisational and administrative controls mentioned herein are set out in our Conflicts Policy, a summary of which (our Summary Conflicts Policy) is available on our website.

This information has been prepared by IG, a trading name of IG Markets Ltd. Registered Office: Cannon Bridge House, 25 Dowgate Hill, London, EC4R 2YA. IG Markets Ltd is a company registered in England and Wales under number 04008957. We are authorised and regulated by the Financial Conduct Authority (Register Number 195355).